Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use

A.Y. Finlay, Ghazala Khan · Clinical and Experimental Dermatology · 1994 · 5.5K citations

Medicine, Dermatology, Allergy +8

Psoriasis causes as much disability as other major medical diseases

Stephen R. Rapp, Steven R. Feldman, M. Lyn Exum et al. · Journal of the American Academy of Dermatology · 1999 · 1.5K citations

Medicine, Clinical Sciences, Dermatology +12

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text

Medicine, Immunology, Pharmacology +17

User’s manual for the SF-12v2 health survey

JE Ware, Michal Kosinski, Dawn Bowker et al. · 2002 · 1.1K citations

Social Sciences, Health Sciences, Psychology +17

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

Ludwig Kappos, Jack P. Antel, Giancarlo Comi et al. · New England Journal of Medicine · 2006 · 1.1K citations · Full text

Pharmacy, Neurology, Pharmacotherapy +8